Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

LXRX Lexicon Pharmaceuticals Inc

1,81

-0,03 (-1,63%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Lexicon Pharmaceuticals Charts.

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Lexicon Pharmaceuticals Charts.

News Lexicon Pharmaceuticals Inc

Form EFFECT - Notice of Effectiveness
Donnerstag 16 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dienstag 14 Mai 2024 (5 Tage vor) • Edgar (US Regulatory)

New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction
Dienstag 14 Mai 2024 (5 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Freitag 10 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 10 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
Donnerstag 9 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Donnerstag 2 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Weitere Lexicon Pharmaceuticals Inc News-Artikel

MELANION BITCOIN EQUITIE...

Denarius Metals

Flexible Solutions

ISHARES ICHD INAV

Coinshares Digital Secur...

Goldman Sachs Bank Usa P...

Citigroup Global Markets...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen